Inhibitory control test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy

American Journal of Gastroenterology

Volumn 102, Issue 4, 2007, Pages 754-760

  Bajaj, Jasmohan S ^a   Saeian, Kia ^a   Verber, Matthew D ^a   Hischke, Darrell ^a   Hoffmann, Raymond G ^a   Franco, Jose ^a   Varma, Rajiv R ^a   Rao, Stephen M ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROL GROUP; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE COURSE; EDUCATION; FEMALE; FOLLOW UP; HEPATIC ENCEPHALOPATHY; HUMAN; INHIBITORY CONTROL TEST; INTERMETHOD COMPARISON; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; PROGNOSIS; PSYCHOMETRY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TARGET VARIABLE; TEST RETEST RELIABILITY;

ATTENTION; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 33947674810     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01048.x     Document Type: Article

References (25)

1. Amodio P, Del Piccolo F, Marchetti P, et al. Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests. Hepatology 1999;29:1662-7.
2. Weissenborn K, Ennen JC, Schomerus H, et al. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 2001;34:768-73.
3. Schiff S, Vallesi A, Mapelli D, et al. Impairment of response inhibition precedes motor alteration in the early stage of liver cirrhosis: A behavioral and electrophysiological study. Metab Brain Dis 2005;20:381-92.
4. Das A, Dhiman RK, Saraswat VA, et al. Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis. J Gastroenterol Hepatol 2001;16:531-5.
5. Romero-Gomez M, Boza F, Garcia-Valdecasas MS, et al. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 2001;96:2718-23.
6. Saxena N, Bhatia M, Joshi YK, et al. Electrophysiological and neuropsychological tests for the diagnosis of subclinical hepatic encephalopathy and prediction of overt encephalopathy. Liver 2002;22:190-7.
7. Wein C, Koch H, Popp B, et al. Minimal hepatic encephalopathy impairs fitness to drive. Hepatology 2004;39:739-45.
8. Groeneweg M, Quero JC, De Bruijn I, et al. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 1998;28:45-9.
9. Vergara-Gomez M, Flavia-Olivella M, Gil-Prades M, et al. [Diagnosis and treatment of hepatic encephalopathy in Spain: Results of a survey of hepatologists]. Gastroenterol Hepatol 2006;29:1-6.
10. Ferenci P, Lockwood A, Mullen K, et al. Hepatic encephalopathy- definition, nomenclature, diagnosis, and quantification: Final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002;35:716-21.
11. Wechsler D. Wechsler Adult Intelligence Scale-III. San Antonio, TX: Psychological Corp, 1999.
12. Garavan H, Ross TJ, Stein EA. Right hemispheric dominance of inhibitory control:Anevent-related functional MRI study. Proc Natl Acad Sci U S A 1999;96:8301-6.
13. Konrad K, Gauggel S, Manz A, et al. Inhibitory control in children with traumatic brain injury (TBI) and children with attention deficit/hyperactivity disorder (ADHD). Brain Inj 2000;14:859-75.
14. Pliszka SR, Liotti M, Woldorff MG. Inhibitory control in children with attention-deficit/hyperactivity disorder: Event-related potentials identify the processing component and timing of an impaired right-frontal response-inhibition mechanism. Biol Psychiatry 2000;48:238-46.
15. Ford JM, Gray M, Whitfield SL, et al. Acquiring and inhibiting prepotent responses in schizophrenia: Event-related brain potentials and functional magnetic resonance imaging. Arch Gen Psychiatry 2004;61:119-29.
16. Bajaj JS, Verber MD, Rao SM, et al. Inhibitory control test is a simple, computerized test to diagnose minimal hepatic encephalopathy (abstract). Hepatology 2004;40:225A.
17. Talwalkar JA, Kamath PS. Influence of recent advances in medical management on clinical outcomes of cirrhosis. Mayo Clin Proc 2005;80:1501-8.
18. Noble JA, Caces MF, Steffens RA, et al. Cirrhosis hospitalization and mortality trends, 1970-87. Public Health Rep 1993;108:192-7.
19. Watanabe A, Sakai T, Sato S, et al. Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy. Hepatology 1997;26:1410-4.
20. Cordoba J, Flavia M, Jacas C, et al. Quality of life and cognitive function in hepatitis C at different stages of liver disease. J Hepatol 2003;39:231-8.
21. Hilsabeck RC, Perry W, Hassanein TI. Neuropsychological impairment in patients with chronic hepatitis C. Hepatology 2002;35:440-6.
22. McAndrews MP, Farcnik K, Carlen P, et al. Prevalence and significance of neurocognitive dysfunction in hepatitis C in the absence of correlated risk factors. Hepatology 2005;41:801-8.
23. Ballard JC. Assessing attention: Comparison of responseinhibition and traditional continuous performance tests. J Clin Exp Neuropsychol 2001;23:331-50.
24. Walker AJ, Shores EA, Trollor JN, et al. Neuropsychological functioning of adults with attention deficit hyperactivity disorder. J Clin Exp Neuropsychol 2000;22:115-24.
25. U.S. Consus Bureau. Current population survey. http://www.census.gov/ population/socdemo/education/cps2004/tab01-01.pdf. Accessed July 11, 2006.